Simon F. Leicht
Papers
1
Total Citations
28
H-Index
1
About
Dr. Simon F. Leicht is a leading ophthalmology researcher whose work focuses on the intersection of radiation oncology and ocular disease, particularly in the management of uveal melanoma. His most cited study, "Incidence of secondary glaucoma after treatment of uveal melanoma with robotic radiosurgery versus brachytherapy" (2017, 28 citations), provides critical comparative data on treatment outcomes. This work directly addresses a major clinical challenge: while modern radiation therapies effectively treat uveal melanoma while preserving the eye, they carry significant risks of secondary complications. Dr. Leicht's research demonstrates that secondary glaucoma—a sight-threatening side effect—occurs at different rates depending on the radiation modality used, with robotic radiosurgery showing distinct advantages over traditional brachytherapy in certain cases. His findings have helped refine treatment protocols, enabling clinicians to better balance tumor control with long-term ocular health. By quantifying these risks, Dr. Leicht has made a lasting impact on clinical decision-making for patients facing this rare but serious cancer. His work continues to influence how radiation oncologists and ophthalmologists collaborate to preserve both life and vision.
Research Focus
Key Achievements
Top Papers
- 1